- Preparation / pathway
- GOLD compounded sildenafil, tadalafil, apomorphine and oxytocin chew
- Published price
- Current GOLD strength-and-quantity price unresolved here
- Conditions to confirm
- Three strengths are described. Obtain a selected quote, including clinical review, supply, delivery and recurring charges.
The GOLD record identifies four ingredients
BlueChew's reviewed plan page describes GOLD with sildenafil, tadalafil, apomorphine and oxytocin and presents three strengths. This record concerns that public offer. It does not assume that a prior BlueChew plan or formulation remains the relevant comparison. [Current plan page]
Ask which strength and dispensing instructions are proposed and why. The preparation's ability to be chewed does not itself establish a faster response or superior result. A pharmacist can also clarify questions about the actual dispensing label. The actual ingredient list should be available for the clinician reviewing other medicines.
The purchase record needs a complete quote
A current total for every GOLD strength and quantity was not established in the retained material. Request the selected number of units, amount collected, consultation arrangement and delivery charge. Include the next billing event if the purchase repeats.
Ask whether a clinical change and a subscription change require separate actions. Do not fill an unresolved GOLD price with a remembered figure from an older plan. We have not created a patient account, submitted health information or tested cancellation and delivery, so no service-performance score is assigned.
The proof record cannot stop at the ingredient list
Compounded drugs are not FDA-approved. A combination of recognizable ingredients is not evidence of a specific onset, duration or emotional-connection benefit. The Viagra label cautions against combination with other PDE5 inhibitors or ED therapies; this is a point for a direct discussion about the proposed preparation. [FDA] [Label]
NIDDK includes examination and possible tests in its diagnostic overview. Ask how the service handles concerns requiring a different setting. See the medicine-identity guide and the pharmacy guide for additional review questions. This profile records public claims and their limits without independently validating BlueChew's outcomes, dispensing operations or suitability for any individual. [Assessment]
Source record
Accessed October 6, 2026. Medical resources and labeling supply general context. Provider-owned pages establish advertised terms, not independently tested outcomes.
- BlueChew: Plans and GOLD formulationProvider-owned product page
- FDA: Compounding questions and answersRegulatory explanation
- Pfizer: Viagra prescribing and patient informationManufacturer labeling; accessed October 6, 2026
- NIDDK: Diagnosis of erectile dysfunctionFederal patient information